Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

The Member of Parliament (MP) for Korle Klottey in Accra, Dr Zanetor Agyeman-Rawlings, has called for the inclusion of lupus ...

This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune disease ...

The Johns Hopkins Department of Dermatology is seeking volunteers with cutaneous lupus to participate in a research study ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

but this means that lupus presents differently with each person,” said Joseph, who was diagnosed in 2014 after a 15-day hospital stay. The wide-ranging symptoms can include skin rashes ...

Discover how autoimmune conditions target joints, causing pain and inflammation. Learn about 7 conditions, symptoms, and ...